| Multiple myeloma is an incurable bone marrow cancer that kills over 100,000 people every year. Known for its quick and deadly spread, this disease is one of the most challenging to address. As these cancer cells move through different parts of the body, they mutate, outpacing possible treatments. People diagnosed with severe multiple myeloma that is resistant to chemotherapy typically survive for only three to six months. Innovative therapies are desperately needed to prevent the spread of this disease and provide a fighting chance for those who suffer from it. | |
| Michael Mitchell, J. Peter and Geri Skirkanich Assistant Professor of Innovation in Bioengineering (BE), and Christian Figueroa-Espada, doctoral student in BE at the University of Pennsylvania School of Engineering and Applied Science, created an RNA nanoparticle therapy that makes it impossible for multiple myeloma to move and mutate. The treatment, described in their study published in PNAS (“In vivo bone marrow microenvironment siRNA delivery using lipid–polymer nanoparticles for multiple myeloma therapy”), turns off a cancer-attracting function in blood vessels, disabling the pathways through which multiple myeloma cells travel. |
| By shutting down this “chemical GPS” that induces the migration of cancer cells, the team’s therapy stops the spread of multiple myeloma, helping to eliminate it altogether. | |
| Endothelial cells, those that line blood vessels, produce a protein we need to survive. This protein, CyPA, is responsible for folding and transporting other proteins. It also activates T-cell responses when we get sick. | |
| However, when multiple myeloma is present, endothelial cells overexpress CyPA and secrete it into the blood vessels where its functions become malignant. Here, CyPA is a chemo-attractant, meaning it pulls multiple myeloma cells from the bone marrow into the blood vessels where they travel quickly to other bones in the body. | |
| “To stop the spread, we aimed to turn off this function of CyPA using RNA therapy, targeting the microenvironment of the cancer instead of the cancer cell itself,” says Mitchell. “But getting nucleic acids into the marrow was challenging due to the complex biological barriers.” | |
| To get the RNA into the hard-to-reach bone marrow, the team needed to redesign the traditional delivery vehicle for the lipid nanoparticle. | |
| “We designed a new hybrid nanoparticle that could deliver small interfering RNA (siRNA) to endothelial cells,” says Figueroa-Espada. “The siRNA stops cells from producing CyPA. When tested in vitro, the therapy prevented the spread of cancer cells. When tested in mice, both alone and in combination with chemotherapies, our therapy was able to decrease the size of tumors, extend survival rates and decrease the cancer’s resistance to chemotherapy.” | |
| “This work can help improve current treatments for multiple myeloma as well as other cancers that spread through the blood vessels,” adds Mitchell. “Using our platform for targeted nanoparticle development, we are looking forward to investigating other cancers and diseases where CyPA is overexpressed.” | |
| By creating a roadblock in cancer’s commute through the body, the Penn Engineering team is removing a longstanding barrier in the treatment of multiple myeloma, providing real hope for people diagnosed with this disease. | |
| In future work, the team plans to investigate silencing additional functions in the microenvironments of cancers to better overcome drug resistance, cancer initiation, and metastasis. They are currently working with Ruben Carrasco, Professor of Pathology at the Dana-Farber Cancer Institute and co-corresponding author of this study, to identify potential targets for this kind of therapy. Once RNA nanoparticle therapy is proven safe in larger animals, this proof-of-concept study can move forward to clinical trials. |
| Source: By Melissa Pappas, University of Pennsylvania (Note: Content may be edited for style and length) |
News
Vision can be rebooted in adults with amblyopia, study suggests
Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic eye, new research shows. In the common vision [...]
Ultrasound-activated Nanoparticles Kill Liver Cancer and Activate Immune System
A new ultrasound-guided nanotherapy wipes out liver tumors while training the immune system to keep them from coming back. The study, published in Nano Today, introduces a biodegradable nanoparticle system that combines sonodynamic therapy and cell [...]
Magnetic nanoparticles that successfully navigate complex blood vessels may be ready for clinical trials
Every year, 12 million people worldwide suffer a stroke; many die or are permanently impaired. Currently, drugs are administered to dissolve the thrombus that blocks the blood vessel. These drugs spread throughout the entire [...]
Reviving Exhausted T Cells Sparks Powerful Cancer Tumor Elimination
Scientists have discovered how tumors secretly drain the energy from T cells—the immune system’s main cancer fighters—and how blocking that process can bring them back to life. The team found that cancer cells use [...]
Very low LDL-cholesterol correlates to fewer heart problems after stroke
Brigham and Women's Hospital's TIMI Study Group reports that in patients with prior ischemic stroke, very low achieved LDL-cholesterol correlated with fewer major adverse cardiovascular events and fewer recurrent strokes, without an apparent increase [...]
“Great Unified Microscope” Reveals Hidden Micro and Nano Worlds Inside Living Cells
University of Tokyo researchers have created a powerful new microscope that captures both forward- and back-scattered light at once, letting scientists see everything from large cell structures to tiny nanoscale particles in a single shot. Researchers [...]
Breakthrough Alzheimer’s Drug Has a Hidden Problem
Researchers in Japan found that although the Alzheimer’s drug lecanemab successfully removes amyloid plaques from the brain, it does not restore the brain’s waste-clearing system within the first few months of treatment. The study suggests that [...]
Concerning New Research Reveals Colon Cancer Is Skyrocketing in Adults Under 50
Colorectal cancer is striking younger adults at alarming rates, driven by lifestyle and genetic factors. Colorectal cancer (CRC) develops when abnormal cells grow uncontrollably in the colon or rectum, forming tumors that can eventually [...]
Scientists Discover a Natural, Non-Addictive Way To Block Pain That Could Replace Opioids
Scientists have discovered that the body can naturally dull pain through its own localized “benzodiazepine-like” peptides. A groundbreaking study led by a University of Leeds scientist has unveiled new insights into how the body manages pain, [...]
GLP-1 Drugs Like Ozempic Work, but New Research Reveals a Major Catch
Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded studies raise concerns. Three new reviews from Cochrane have found that GLP-1 medications can lead to significant [...]
How a Palm-Sized Laser Could Change Medicine and Manufacturing
Researchers have developed an innovative and versatile system designed for a new generation of short-pulse lasers. Lasers that produce extremely short bursts of light are known for their remarkable precision, making them indispensable tools [...]
New nanoparticles stimulate the immune system to attack ovarian tumors
Cancer immunotherapy, which uses drugs that stimulate the body’s immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn’t work well for some tumors, including ovarian [...]
New Drug Kills Cancer 20,000x More Effectively With No Detectable Side Effects
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned the molecular structure of a well-known chemotherapy drug, greatly [...]
Lipid nanoparticles discovered that can deliver mRNA directly into heart muscle cells
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC Berkeley-led [...]
The basic mechanisms of visual attention emerged over 500 million years ago, study suggests
The brain does not need its sophisticated cortex to interpret the visual world. A new study published in PLOS Biology demonstrates that a much older structure, the superior colliculus, contains the necessary circuitry to perform the [...]
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
